Literature DB >> 31970210

Spinocerebellar Ataxia Patient Perceptions Regarding Reproductive Options.

Suzanne Cahn1, Ami Rosen2,3, George Wilmot3.   

Abstract

BACKGROUND: In vitro fertilization with preimplantation genetic testing is a growing reproductive option for people who want to avoid passing a single-gene condition on to their offspring. The spinocerebellar ataxias are a group of rare, autosomal-dominant neurodegenerative disorders which are strong candidates for the use of this technology.
OBJECTIVES: This study aimed to assess knowledge of genetic risk and perceptions of reproductive options in individuals with a diagnosis of spinocerebellar ataxia.
METHODS: We administered an online survey to U.S. residents of reproductive age who have been clinically or genetically diagnosed with spinocerebellar ataxia. We assessed their understanding of inheritance and their reproductive opinions.
RESULTS: Of 94 participants, 70.2% answered all four inheritance questions correctly. The majority felt they could describe each reproductive option except prenatal diagnosis. Individuals were most interested in in vitro fertilization with preimplantation genetic testing: 48.4% (45 of 93) said they would consider it. They were least interested in prenatal diagnosis and donated embryos or gametes. Having spinocerebellar ataxia with anticipation and choosing inheritance risk as an important factor were both significantly associated with interest in preimplantation genetic testing. Choosing religion/morality as an important factor was associated with less interest in preimplantation genetic testing and prenatal diagnosis.
CONCLUSIONS: Our population displayed basic knowledge of inheritance risk, and the majority wanted to avoid having affected children. Consistent with literature for other autosomal-dominant adult-onset conditions, individuals showed a preference for preimplantation genetic testing. Health care providers should continue to educate patients about reproductive options and their risks and limitations.
© 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  assisted reproductive technology; ataxia; preimplantation genetic diagnosis; prenatal diagnosis; reproductive decisions

Year:  2019        PMID: 31970210      PMCID: PMC6962671          DOI: 10.1002/mdc3.12859

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  32 in total

1.  ESHRE PGD Consortium data collection VIII: cycles from January to December 2005 with pregnancy follow-up to October 2006.

Authors:  V Goossens; G Harton; C Moutou; P N Scriven; J Traeger-Synodinos; K Sermon; J C Harper
Journal:  Hum Reprod       Date:  2008-07-18       Impact factor: 6.918

2.  Impact of Huntington Disease Gene-Positive Status on Pre-Symptomatic Young Adults and Recommendations for Genetic Counselors.

Authors:  Ping Gong; Joanna H Fanos; Lauren Korty; Carly E Siskind; Andrea K Hanson-Kahn
Journal:  J Genet Couns       Date:  2016-04-22       Impact factor: 2.537

Review 3.  Preimplantation genetic diagnosis: technical advances and expanding applications.

Authors:  Stephen C Collins
Journal:  Curr Opin Obstet Gynecol       Date:  2013-06       Impact factor: 1.927

Review 4.  Preimplantation genetic diagnosis for inherited neurological disorders.

Authors:  Ilan Tur-Kaspa; Roohi Jeelani; P Murali Doraiswamy
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

5.  ESHRE PGD Consortium data collection XII: cycles from January to December 2009 with pregnancy follow-up to October 2010.

Authors:  C Moutou; V Goossens; E Coonen; M De Rycke; G Kokkali; P Renwick; S B SenGupta; K Vesela; J Traeger-Synodinos
Journal:  Hum Reprod       Date:  2014-03-11       Impact factor: 6.918

6.  Experience over fifteen years with a protocol for predictive testing for Huntington disease.

Authors:  Suzanne Dufrasne; Madeleine Roy; Maria Galvez; David S Rosenblatt
Journal:  Mol Genet Metab       Date:  2010-12-13       Impact factor: 4.797

7.  ESHRE PGD Consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011.

Authors:  M De Rycke; F Belva; V Goossens; C Moutou; S B SenGupta; J Traeger-Synodinos; E Coonen
Journal:  Hum Reprod       Date:  2015-06-12       Impact factor: 6.918

8.  Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000.

Authors:  S Creighton; E W Almqvist; D MacGregor; B Fernandez; H Hogg; J Beis; J P Welch; C Riddell; R Lokkesmoe; M Khalifa; J MacKenzie; A Sajoo; S Farrell; F Robert; A Shugar; A Summers; W Meschino; D Allingham-Hawkins; T Chiu; A Hunter; J Allanson; H Hare; J Schween; L Collins; S Sanders; C Greenberg; S Cardwell; E Lemire; P MacLeod; M R Hayden
Journal:  Clin Genet       Date:  2003-06       Impact factor: 4.438

9.  Attitudes of high-risk women toward preimplantation genetic diagnosis.

Authors:  Gwendolyn Quinn; Susan Vadaparampil; Crystal Wilson; Lindsey King; Jimin Choi; Cheryl Miree; Sue Friedman
Journal:  Fertil Steril       Date:  2008-04-28       Impact factor: 7.329

10.  Attitude towards pre-implantation genetic diagnosis for hereditary cancer.

Authors:  Chantal Lammens; Eveline Bleiker; Neil Aaronson; Annette Vriends; Margreet Ausems; Maaike Jansweijer; Anja Wagner; Rolf Sijmons; Ans van den Ouweland; Rob van der Luijt; Liesbeth Spruijt; Encarna Gómez García; Mariëlle Ruijs; Senno Verhoef
Journal:  Fam Cancer       Date:  2009-07-30       Impact factor: 2.375

View more
  2 in total

Review 1.  Genetic counseling and testing practices for late-onset neurodegenerative disease: a systematic review.

Authors:  Ashley Crook; Chris Jacobs; Toby Newton-John; Rosie O'Shea; Alison McEwen
Journal:  J Neurol       Date:  2021-03-01       Impact factor: 6.682

2.  Role of telomere shortening in anticipation of inflammatory bowel disease.

Authors:  Brindusa Truta; Elizabeth Wohler; Nara Sobreira; Lisa W Datta; Steven R Brant
Journal:  World J Gastrointest Pharmacol Ther       Date:  2020-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.